Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
Consensus-based care recommendations for adults with myotonic dystrophy type 1.

Neurology. Clinical practice

Ashizawa T, Gagnon C, Groh WJ, Gutmann L, Johnson NE, Meola G, Moxley R, Pandya S, Rogers MT, Simpson E, Angeard N, Bassez G, Berggren KN, Bhakta D, Bozzali M, Broderick A, Byrne JLB, Campbell C, Cup E, Day JW, De Mattia E, Duboc D, Duong T, Eichinger K, Ekstrom AB, van Engelen B, Esparis B, Eymard B, Ferschl M, Gadalla SM, Gallais B, Goodglick T, Heatwole C, Hilbert J, Holland V, Kierkegaard M, Koopman WJ, Lane K, Maas D, Mankodi A, Mathews KD, Monckton DG, Moser D, Nazarian S, Nguyen L, Nopoulos P, Petty R, Phetteplace J, Puymirat J, Raman S, Richer L, Roma E, Sampson J, Sansone V, Schoser B, Sterling L, Statland J, Subramony SH, Tian C, Trujillo C, Tomaselli G, Turner C, Venance S, Verma A, White M, Winblad S.
PMID: 30588381
Neurol Clin Pract. 2018 Dec;8(6):507-520. doi: 10.1212/CPJ.0000000000000531.

PURPOSE OF REVIEW: Myotonic dystrophy type 1 (DM1) is a severe, progressive genetic disease that affects between 1 in 3,000 and 8,000 individuals globally. No evidence-based guideline exists to inform the care of these patients, and most do not...

Cite
Ashizawa T, Gagnon C, Groh WJ, et al. Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract. 2018;8(6):507-520doi: 10.1212/CPJ.0000000000000531.
Ashizawa, T., Gagnon, C., Groh, W. J., Gutmann, L., Johnson, N. E., Meola, G., Moxley, R., Pandya, S., Rogers, M. T., Simpson, E., Angeard, N., Bassez, G., Berggren, K. N., Bhakta, D., Bozzali, M., Broderick, A., Byrne, J. L. B., Campbell, C., Cup, E., Day, J. W., De Mattia, E., Duboc, D., Duong, T., Eichinger, K., Ekstrom, A. B., van Engelen, B., Esparis, B., Eymard, B., Ferschl, M., Gadalla, S. M., Gallais, B., Goodglick, T., Heatwole, C., Hilbert, J., Holland, V., Kierkegaard, M., Koopman, W. J., Lane, K., Maas, D., Mankodi, A., Mathews, K. D., Monckton, D. G., Moser, D., Nazarian, S., Nguyen, L., Nopoulos, P., Petty, R., Phetteplace, J., Puymirat, J., Raman, S., Richer, L., Roma, E., Sampson, J., Sansone, V., Schoser, B., Sterling, L., Statland, J., Subramony, S. H., Tian, C., Trujillo, C., Tomaselli, G., Turner, C., Venance, S., Verma, A., White, M., & Winblad, S. (2018). Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurology. Clinical practice, 8(6), 507-520. https://doi.org/10.1212/CPJ.0000000000000531
Ashizawa, Tetsuo, et al. "Consensus-based care recommendations for adults with myotonic dystrophy type 1." Neurology. Clinical practice vol. 8,6 (2018): 507-520. doi: https://doi.org/10.1212/CPJ.0000000000000531
Ashizawa T, Gagnon C, Groh WJ, Gutmann L, Johnson NE, Meola G, Moxley R, Pandya S, Rogers MT, Simpson E, Angeard N, Bassez G, Berggren KN, Bhakta D, Bozzali M, Broderick A, Byrne JLB, Campbell C, Cup E, Day JW, De Mattia E, Duboc D, Duong T, Eichinger K, Ekstrom AB, van Engelen B, Esparis B, Eymard B, Ferschl M, Gadalla SM, Gallais B, Goodglick T, Heatwole C, Hilbert J, Holland V, Kierkegaard M, Koopman WJ, Lane K, Maas D, Mankodi A, Mathews KD, Monckton DG, Moser D, Nazarian S, Nguyen L, Nopoulos P, Petty R, Phetteplace J, Puymirat J, Raman S, Richer L, Roma E, Sampson J, Sansone V, Schoser B, Sterling L, Statland J, Subramony SH, Tian C, Trujillo C, Tomaselli G, Turner C, Venance S, Verma A, White M, Winblad S. Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract. 2018 Dec;8(6):507-520. doi: 10.1212/CPJ.0000000000000531. PMID: 30588381; PMCID: PMC6294540.
Copy Download .nbib Format: NLM
Rescue Decompressive Craniectomy in Children with Severe Traumatic Brain Injury.

Journal of pediatric intensive care

Rallis D, Poulos P, Kazantzi M, Kalampalikis P.
PMID: 31073464
J Pediatr Intensive Care. 2018 Mar;7(1):33-38. doi: 10.1055/s-0037-1603825. Epub 2017 Jun 19.

Decompressive craniectomy (DC) is considered a rescue therapy in patients with traumatic brain injury (TBI) with increased intracranial pressure (ICP). In this retrospective study, we examined the impact of craniectomy on ICP in children with severe TBI and their...

Cite
Rallis D, Poulos P, Kazantzi M, et al. Rescue Decompressive Craniectomy in Children with Severe Traumatic Brain Injury. J Pediatr Intensive Care. 2017;7(1):33-38doi: 10.1055/s-0037-1603825.
Rallis, D., Poulos, P., Kazantzi, M., & Kalampalikis, P. (2018). Rescue Decompressive Craniectomy in Children with Severe Traumatic Brain Injury. Journal of pediatric intensive care, 7(1), 33-38. https://doi.org/10.1055/s-0037-1603825
Rallis, Dimitrios, et al. "Rescue Decompressive Craniectomy in Children with Severe Traumatic Brain Injury." Journal of pediatric intensive care vol. 7,1 (2018): 33-38. doi: https://doi.org/10.1055/s-0037-1603825
Rallis D, Poulos P, Kazantzi M, Kalampalikis P. Rescue Decompressive Craniectomy in Children with Severe Traumatic Brain Injury. J Pediatr Intensive Care. 2018 Mar;7(1):33-38. doi: 10.1055/s-0037-1603825. Epub 2017 Jun 19. PMID: 31073464; PMCID: PMC6260332.
Copy Download .nbib Format: NLM
Sex Differences in the Association of Pre-Transfusion Hemoglobin Levels with Brain Structure and Function in the Preterm Infant.

The Journal of pediatrics

Benavides A, Bell EF, Conrad AL, Feldman HA, Georgieff MK, Josephson CD, Koscik T, Stowell SR, Sola-Visner M, Nopoulos P.
PMID: 34968498
J Pediatr. 2021 Dec 27; doi: 10.1016/j.jpeds.2021.12.051. Epub 2021 Dec 27.

OBJECTIVE: To assess sex-specific differences in early brain structure and function of preterm infants after red blood cell (RBC) transfusions.STUDY DESIGN: A single-center subset of infants with a birth weight

Cite
Benavides A, Bell EF, Conrad AL, et al. Sex Differences in the Association of Pre-Transfusion Hemoglobin Levels with Brain Structure and Function in the Preterm Infant. J Pediatr. 2021;doi: 10.1016/j.jpeds.2021.12.051.
Benavides, A., Bell, E. F., Conrad, A. L., Feldman, H. A., Georgieff, M. K., Josephson, C. D., Koscik, T., Stowell, S. R., Sola-Visner, M., & Nopoulos, P. (2021). Sex Differences in the Association of Pre-Transfusion Hemoglobin Levels with Brain Structure and Function in the Preterm Infant. The Journal of pediatrics, . https://doi.org/10.1016/j.jpeds.2021.12.051
Benavides, Amanda, et al. "Sex Differences in the Association of Pre-Transfusion Hemoglobin Levels with Brain Structure and Function in the Preterm Infant." The Journal of pediatrics vol. (2021). doi: https://doi.org/10.1016/j.jpeds.2021.12.051
Benavides A, Bell EF, Conrad AL, Feldman HA, Georgieff MK, Josephson CD, Koscik T, Stowell SR, Sola-Visner M, Nopoulos P. Sex Differences in the Association of Pre-Transfusion Hemoglobin Levels with Brain Structure and Function in the Preterm Infant. J Pediatr. 2021 Dec 27; doi: 10.1016/j.jpeds.2021.12.051. Epub 2021 Dec 27. PMID: 34968498.
Copy Download .nbib Format: NLM
Sex-specific cytokine responses and neurocognitive outcome after blood transfusions in preterm infants.

Pediatric research

Benavides A, Bell EF, Georgieff MK, Josephson CD, Stowell SR, Feldman HA, Nalbant D, Tereshchenko A, Sola-Visner M, Nopoulos P.
PMID: 33911194
Pediatr Res. 2021 Apr 28; doi: 10.1038/s41390-021-01536-0. Epub 2021 Apr 28.

BACKGROUND: The objective of this study was to determine sex-specific differences in inflammatory cytokine responses to red blood cell (RBC) transfusion in preterm infants in the neonatal period and their relationship to later neurocognitive status.METHODS: Infants with a birth...

Cite
Benavides A, Bell EF, Georgieff MK, et al. Sex-specific cytokine responses and neurocognitive outcome after blood transfusions in preterm infants. Pediatr Res. 2021;doi: 10.1038/s41390-021-01536-0.
Benavides, A., Bell, E. F., Georgieff, M. K., Josephson, C. D., Stowell, S. R., Feldman, H. A., Nalbant, D., Tereshchenko, A., Sola-Visner, M., & Nopoulos, P. (2021). Sex-specific cytokine responses and neurocognitive outcome after blood transfusions in preterm infants. Pediatric research, . https://doi.org/10.1038/s41390-021-01536-0
Benavides, Amanda, et al. "Sex-specific cytokine responses and neurocognitive outcome after blood transfusions in preterm infants." Pediatric research vol. (2021). doi: https://doi.org/10.1038/s41390-021-01536-0
Benavides A, Bell EF, Georgieff MK, Josephson CD, Stowell SR, Feldman HA, Nalbant D, Tereshchenko A, Sola-Visner M, Nopoulos P. Sex-specific cytokine responses and neurocognitive outcome after blood transfusions in preterm infants. Pediatr Res. 2021 Apr 28; doi: 10.1038/s41390-021-01536-0. Epub 2021 Apr 28. PMID: 33911194; PMCID: PMC8551306.
Copy Download .nbib Format: NLM
Abnormal Brain Development in Huntington' Disease Is Recapitulated in the zQ175 Knock-In Mouse Model.

Cerebral cortex communications

Zhang C, Wu Q, Liu H, Cheng L, Hou Z, Mori S, Hua J, Ross CA, Zhang J, Nopoulos PC, Duan W.
PMID: 32984817
Cereb Cortex Commun. 2020;1(1):tgaa044. doi: 10.1093/texcom/tgaa044. Epub 2020 Aug 05.

Emerging cellular and molecular studies are providing compelling evidence that altered brain development contributes to the pathogenesis of Huntington's disease (HD). There has been lacking longitudinal system-level data obtained from

Cite
Zhang C, Wu Q, Liu H, et al. Abnormal Brain Development in Huntington' Disease Is Recapitulated in the zQ175 Knock-In Mouse Model. Cereb Cortex Commun. 2020;1(1):tgaa044doi: 10.1093/texcom/tgaa044.
Zhang, C., Wu, Q., Liu, H., Cheng, L., Hou, Z., Mori, S., Hua, J., Ross, C. A., Zhang, J., Nopoulos, P. C., & Duan, W. (2020). Abnormal Brain Development in Huntington' Disease Is Recapitulated in the zQ175 Knock-In Mouse Model. Cerebral cortex communications, 1(1), tgaa044. https://doi.org/10.1093/texcom/tgaa044
Zhang, Chuangchuang, et al. "Abnormal Brain Development in Huntington' Disease Is Recapitulated in the zQ175 Knock-In Mouse Model." Cerebral cortex communications vol. 1,1 (2020): tgaa044. doi: https://doi.org/10.1093/texcom/tgaa044
Zhang C, Wu Q, Liu H, Cheng L, Hou Z, Mori S, Hua J, Ross CA, Zhang J, Nopoulos PC, Duan W. Abnormal Brain Development in Huntington' Disease Is Recapitulated in the zQ175 Knock-In Mouse Model. Cereb Cortex Commun. 2020;1(1):tgaa044. doi: 10.1093/texcom/tgaa044. Epub 2020 Aug 05. PMID: 32984817; PMCID: PMC7501464.
Copy Download .nbib Format: NLM
Sleep disturbances by disease type and stage in Huntington's disease.

Parkinsonism & related disorders

Ogilvie AC, Nopoulos PC, Schultz JL.
PMID: 34450461
Parkinsonism Relat Disord. 2021 Oct;91:13-18. doi: 10.1016/j.parkreldis.2021.08.011. Epub 2021 Aug 21.

INTRODUCTION: Sleep disturbances are a common symptom in patients with Huntington's disease (HD). However, it is unclear when in the disease course of HD sleep disturbances become more frequent compared to the general population. This study investigated the frequency...

Cite
Ogilvie AC, Nopoulos PC, Schultz JL. Sleep disturbances by disease type and stage in Huntington's disease. Parkinsonism Relat Disord. 2021;91:13-18doi: 10.1016/j.parkreldis.2021.08.011.
Ogilvie, A. C., Nopoulos, P. C., & Schultz, J. L. (2021). Sleep disturbances by disease type and stage in Huntington's disease. Parkinsonism & related disorders, 9113-18. https://doi.org/10.1016/j.parkreldis.2021.08.011
Ogilvie, Amy C, et al. "Sleep disturbances by disease type and stage in Huntington's disease." Parkinsonism & related disorders vol. 91 (2021): 13-18. doi: https://doi.org/10.1016/j.parkreldis.2021.08.011
Ogilvie AC, Nopoulos PC, Schultz JL. Sleep disturbances by disease type and stage in Huntington's disease. Parkinsonism Relat Disord. 2021 Oct;91:13-18. doi: 10.1016/j.parkreldis.2021.08.011. Epub 2021 Aug 21. PMID: 34450461.
Copy Download .nbib Format: NLM
Subcortical T1-Rho MRI Abnormalities in Juvenile-Onset Huntington's Disease.

Brain sciences

Tereshchenko AV, Schultz JL, Kunnath AJ, Bruss JE, Epping EA, Magnotta VA, Nopoulos PC.
PMID: 32784364
Brain Sci. 2020 Aug 08;10(8). doi: 10.3390/brainsci10080533.

Huntington's disease (HD) is a fatal neurodegenerative disease caused by the expansion of cytosine-adenine-guanine (CAG) repeats in the

Cite
Tereshchenko AV, Schultz JL, Kunnath AJ, et al. Subcortical T1-Rho MRI Abnormalities in Juvenile-Onset Huntington's Disease. Brain Sci. 2020;10(8)doi: 10.3390/brainsci10080533.
Tereshchenko, A. V., Schultz, J. L., Kunnath, A. J., Bruss, J. E., Epping, E. A., Magnotta, V. A., & Nopoulos, P. C. (2020). Subcortical T1-Rho MRI Abnormalities in Juvenile-Onset Huntington's Disease. Brain sciences, 10(8), . https://doi.org/10.3390/brainsci10080533
Tereshchenko, Alexander V, et al. "Subcortical T1-Rho MRI Abnormalities in Juvenile-Onset Huntington's Disease." Brain sciences vol. 10,8 (2020). doi: https://doi.org/10.3390/brainsci10080533
Tereshchenko AV, Schultz JL, Kunnath AJ, Bruss JE, Epping EA, Magnotta VA, Nopoulos PC. Subcortical T1-Rho MRI Abnormalities in Juvenile-Onset Huntington's Disease. Brain Sci. 2020 Aug 08;10(8). doi: 10.3390/brainsci10080533. PMID: 32784364; PMCID: PMC7463529.
Copy Download .nbib Format: NLM
Correction: Sex-specific alterations in preterm brain.

Pediatric research

Benavides A, Metzger A, Tereshchenko A, Conrad A, Bell EF, Spencer J, Ross-Sheehy S, Georgieff M, Magnotta V, Nopoulos P.
PMID: 30737490
Pediatr Res. 2019 Apr;85(5):732. doi: 10.1038/s41390-019-0323-x.

In the original article, the legend within Fig. 3 incorrectly read as '*p 

Cite
Benavides A, Metzger A, Tereshchenko A, et al. Correction: Sex-specific alterations in preterm brain. Pediatr Res. 2019;85(5):732doi: 10.1038/s41390-019-0323-x.
Benavides, A., Metzger, A., Tereshchenko, A., Conrad, A., Bell, E. F., Spencer, J., Ross-Sheehy, S., Georgieff, M., Magnotta, V., & Nopoulos, P. (2019). Correction: Sex-specific alterations in preterm brain. Pediatric research, 85(5), 732. https://doi.org/10.1038/s41390-019-0323-x
Benavides, Amanda, et al. "Correction: Sex-specific alterations in preterm brain." Pediatric research vol. 85,5 (2019): 732. doi: https://doi.org/10.1038/s41390-019-0323-x
Benavides A, Metzger A, Tereshchenko A, Conrad A, Bell EF, Spencer J, Ross-Sheehy S, Georgieff M, Magnotta V, Nopoulos P. Correction: Sex-specific alterations in preterm brain. Pediatr Res. 2019 Apr;85(5):732. doi: 10.1038/s41390-019-0323-x. PMID: 30737490.
Copy Download .nbib Format: NLM
Sequential chemo-immunotherapy treatment of metastatic malignant melanoma.

Oncology reports

Ginopoulos P, Spiropoulos K, Alivisatos B, Kardamakis E, Tzingounis V.
PMID: 21594492
Oncol Rep. 1996 Sep;3(5):967-72. doi: 10.3892/or.3.5.967.

Twelve patients with recurring metastatic inoperable malignant melanoma (performance status ECOG 0-1), received the following chemotherapy: tamoxifen p.o., carmustine i.v., dacarbazine i.v., and cisplatin i.v., followed by immunotherapy: interleukin-2 s.c. and interferon-alpha s.c. The treatment cycle was repeated every...

Cite
Ginopoulos P, Spiropoulos K, Alivisatos B, et al. Sequential chemo-immunotherapy treatment of metastatic malignant melanoma. Oncol Rep. 1996;3(5):967-72doi: 10.3892/or.3.5.967.
Ginopoulos, P., Spiropoulos, K., Alivisatos, B., Kardamakis, E., & Tzingounis, V. (1996). Sequential chemo-immunotherapy treatment of metastatic malignant melanoma. Oncology reports, 3(5), 967-72. https://doi.org/10.3892/or.3.5.967
Ginopoulos, P, et al. "Sequential chemo-immunotherapy treatment of metastatic malignant melanoma." Oncology reports vol. 3,5 (1996): 967-72. doi: https://doi.org/10.3892/or.3.5.967
Ginopoulos P, Spiropoulos K, Alivisatos B, Kardamakis E, Tzingounis V. Sequential chemo-immunotherapy treatment of metastatic malignant melanoma. Oncol Rep. 1996 Sep;3(5):967-72. doi: 10.3892/or.3.5.967. PMID: 21594492.
Copy Download .nbib Format: NLM
Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst.

Cell reports

Xenopoulos P, Kang M, Puliafito A, Di Talia S, Hadjantonakis AK.
PMID: 25753417
Cell Rep. 2015 Mar 10;10(9):1508-1520. doi: 10.1016/j.celrep.2015.02.010. Epub 2015 Mar 05.

The pluripotent epiblast (EPI) is the founder tissue of almost all somatic cells. EPI and primitive endoderm (PrE) progenitors arise from the inner cell mass (ICM) of the blastocyst-stage embryo. The EPI lineage is distinctly identified by its expression...

Cite
Xenopoulos P, Kang M, Puliafito A, et al. Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. Cell Rep. 2015;10(9):1508-1520doi: 10.1016/j.celrep.2015.02.010.
Xenopoulos, P., Kang, M., Puliafito, A., Di Talia, S., & Hadjantonakis, A. K. (2015). Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. Cell reports, 10(9), 1508-1520. https://doi.org/10.1016/j.celrep.2015.02.010
Xenopoulos, Panagiotis, et al. "Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst." Cell reports vol. 10,9 (2015): 1508-1520. doi: https://doi.org/10.1016/j.celrep.2015.02.010
Xenopoulos P, Kang M, Puliafito A, Di Talia S, Hadjantonakis AK. Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. Cell Rep. 2015 Mar 10;10(9):1508-1520. doi: 10.1016/j.celrep.2015.02.010. Epub 2015 Mar 05. PMID: 25753417; PMCID: PMC4560681.
Copy Download .nbib Format: NLM
Associations between neurofilament light-chain protein, brain structure, and chronic kidney disease.

Pediatric research

van der Plas E, Lullmann O, Hopkins L, Schultz JL, Nopoulos PC, Harshman LA.
PMID: 34274959
Pediatr Res. 2021 Jul 17; doi: 10.1038/s41390-021-01649-6. Epub 2021 Jul 17.

BACKGROUND: Neurofilament light-chain (NfL) protein is a blood-based marker of neuroaxonal injury. We sought to (1) compare plasma NfL levels in children with chronic kidney disease (CKD) and healthy peers, (2) characterize the relationship between NfL level and kidney...

Cite
van der Plas E, Lullmann O, Hopkins L, et al. Associations between neurofilament light-chain protein, brain structure, and chronic kidney disease. Pediatr Res. 2021;doi: 10.1038/s41390-021-01649-6.
van der Plas, E., Lullmann, O., Hopkins, L., Schultz, J. L., Nopoulos, P. C., & Harshman, L. A. (2021). Associations between neurofilament light-chain protein, brain structure, and chronic kidney disease. Pediatric research, . https://doi.org/10.1038/s41390-021-01649-6
van der Plas, Ellen, et al. "Associations between neurofilament light-chain protein, brain structure, and chronic kidney disease." Pediatric research vol. (2021). doi: https://doi.org/10.1038/s41390-021-01649-6
van der Plas E, Lullmann O, Hopkins L, Schultz JL, Nopoulos PC, Harshman LA. Associations between neurofilament light-chain protein, brain structure, and chronic kidney disease. Pediatr Res. 2021 Jul 17; doi: 10.1038/s41390-021-01649-6. Epub 2021 Jul 17. PMID: 34274959; PMCID: PMC8761779.
Copy Download .nbib Format: NLM
Metabolite and Bioactive Compounds Profiling of Meteora Sea Buckthorn Berries through High-Resolution NMR Analysis.

Metabolites

Zompra AA, Chasapi SA, Karagkouni EC, Karamouzi E, Panopoulos P, Spyroulias GA.
PMID: 34940580
Metabolites. 2021 Nov 30;11(12). doi: 10.3390/metabo11120822.

Sea buckthorn berries (

Cite
Zompra AA, Chasapi SA, Karagkouni EC, et al. Metabolite and Bioactive Compounds Profiling of Meteora Sea Buckthorn Berries through High-Resolution NMR Analysis. Metabolites. 2021;11(12)doi: 10.3390/metabo11120822.
Zompra, A. A., Chasapi, S. A., Karagkouni, E. C., Karamouzi, E., Panopoulos, P., & Spyroulias, G. A. (2021). Metabolite and Bioactive Compounds Profiling of Meteora Sea Buckthorn Berries through High-Resolution NMR Analysis. Metabolites, 11(12), . https://doi.org/10.3390/metabo11120822
Zompra, Aikaterini A, et al. "Metabolite and Bioactive Compounds Profiling of Meteora Sea Buckthorn Berries through High-Resolution NMR Analysis." Metabolites vol. 11,12 (2021). doi: https://doi.org/10.3390/metabo11120822
Zompra AA, Chasapi SA, Karagkouni EC, Karamouzi E, Panopoulos P, Spyroulias GA. Metabolite and Bioactive Compounds Profiling of Meteora Sea Buckthorn Berries through High-Resolution NMR Analysis. Metabolites. 2021 Nov 30;11(12). doi: 10.3390/metabo11120822. PMID: 34940580; PMCID: PMC8705651.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 43 entries